Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06999655 · ClinicalTrials.gov registry record · NA
Radicle Energy: A Study Assessing the Impact of Health and Wellness Products on Fatigue
A NA study, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 750
- Enrollment target
NCT06999655: Completed NA study, sponsored by Radicle Science.
NCT06999655 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 750 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06999655, a NA study, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 750 participants
- Enrollment target
Study Summary
A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on fatigue and related health outcomes
Primary Outcome
Difference between rates of change over time in fatigue score as assessed by Patient Reported Outcome Measurement System (PROMIS) Fatigue 8A (scale 8-40; where the higher scores correspond to more fatigue)
Interventions
- DIETARY_SUPPLEMENT Energy Active Product 1
- DIETARY_SUPPLEMENT Energy Placebo Control
- DIETARY_SUPPLEMENT Energy Active Product 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2025-06-05 |
| Est. Completion | 2025-09-18 |
| Phase | NA |
What the finished NCT06999655 record still lists
NCT06999655 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 3 interventions - of which Energy Active Product 1 is the first listed.
NCT06999655 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06999655 about?
NCT06999655 is a clinical study titled "Radicle Energy: A Study Assessing the Impact of Health and Wellness Products on Fatigue". A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on fatigue and related health outcomes
What is the current status of trial NCT06999655?
This trial is currently completed. It is a NA study. The enrollment target is 750 participants. The study started on 2025-06-05. Estimated completion is 2025-09-18.
What interventions are being tested in trial NCT06999655?
The interventions under investigation include: Energy Active Product 1 (DIETARY_SUPPLEMENT), Energy Placebo Control (DIETARY_SUPPLEMENT), Energy Active Product 2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06999655?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06999655's enrollment target sits among peer trials
750 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI